Fortestatin amide derivatives and their preparation method and application
A technology of tenacin amides and derivatives, which is applied in the field of pancreatic lipase inhibitors, and can solve the problems of no reports on the activity of tenacin amide derivatives, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 2
[0071] Inhibition of pancreatic lipase in vitro:
[0072] 1. Determination of Drugs and Compounds
[0073] The assay compound is vibralactone steastin amide derivatives obtained in Example 1, a total of 12 compounds; the positive drug is Orlistat (Orlistat, N-Formyl-L-leucine (1S)-1-[[(2S, 3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester) was purchased from Sigma; the compound and Orlistat were dissolved in dimethylsulfoxide (DMSO) and stored at 4°C. 2. Reagents and solutions
[0074] (1) Reagents
[0075] Porcine pancreatic lipase (PPL) was purchased from Aladdin Reagent Company; p-nitrophenyl butyrate (p-NPB) and Tris were purchased from Sigma Company; D-PBS was purchased from Hyclone Company; anhydrous calcium chloride was purchased from Chengdu Kelong Chemical Reagent factory products.
[0076] (2) Solution
[0077] Tris buffer containing 100mM Tris, 5mM CaCl 2 , pH value is 7.0, and stored at 4°C; PPL solution is made into 1000U / mL stock solution with D-PBS, aliquo...
Embodiment 3
[0094] The compound was prepared according to Example 1, and excipients were added according to the weight ratio of compound crystals and excipients at a ratio of 1:1, and then granulated and compressed into tablets.
Embodiment 4
[0096] The compound was prepared according to Example 1, and capsules were made into capsules according to conventional capsule preparation methods.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


